Journals / Turkish Journal of Gastroenterology / 2021 / Cilt: 32 - Sayı: 2

Predicting Mucosal Proliferation in Ulcerative Colitis by Assessing Mucosal Vascular Pattern Under Narrow Band Imaging Colonoscopy

Pages
203–208
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The results showed that MVP correlated well with the MES (r = 0.796, P < .001).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Proliferative abnormalities are believed to represent an early phase of colorectal carcinogenesis.
📊
Key Findings & Data:Methods: A total of 119 colorectal lesions were analyzed from 42 patients with UC who underwent NBI colonoscopy.
💡
Conclusion & Impact:Results: The results showed that MVP correlated well with the MES (r = 0.796, P < .001).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background: Proliferative abnormalities are believed to represent an early phase of colorectal carcinogenesis. Narrow band imaging (NBI) colonoscopy allows visual assessment of the mucosal vascular pattern (MVP) without dyeing. The aim of this study was to investigate the predictive value of MVP for mucosal proliferation in ulcerative colitis (UC). Methods: A total of 119 colorectal lesions were analyzed from 42 patients with UC who underwent NBI colonoscopy. Both the MVP and the Mayo endoscopic score (MES) were assessed. The mucosal inflammation was histologically graded using a colitis score. The proliferation marker Ki-67 was assessed by immunohistochemical staining. Results: The results showed that MVP correlated well with the MES (r = 0.796, P < .001). There was moderate correlation between the distribution of Ki-67 staining and MVP (r = 0.492, P < .001), and the Ki-67 labeling index increased with the orderly patterns of MVP (P < .001). An expansion of Ki-67 staining upward from the crypt base may be caused by active inflammation. Conclusion: MVP based on NBI colonoscopy can predict mucosal proliferation which is associated with inflammation in patients with UC.

🔖

Cite This Article

GUO, T., QIAN, J., YANG, A., LI, Y., ZHOU, W. (2021). Predicting Mucosal Proliferation in Ulcerative Colitis by Assessing Mucosal Vascular Pattern Under Narrow Band Imaging Colonoscopy. Turkish Journal of Gastroenterology, Cilt: 32 - Sayı: 2, 203–208. https://ajindex.com/articles/408863

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bye WA, Ma C, Nguyen TM, et al. Strategies for detecting colorectal cancer in patients with inflammatory bowel disease: a Cochrane systematic review and meta-analysis. Am J Gastroenterol. 2018
  2. 113(12):1801-1809. [CrossRef] 2. Mariani F, Sena P, Roncucci L. Inflammatory pathways in the early steps of colorectal cancer development. World J Gastroenterol. 2014
  3. 20(29):9716-9731. [CrossRef] 3. Dulai PS, Sandborn WJ, Gupta S. Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology, and management. Cancer Prev Res (Phila). 2016
  4. 9(12):887-894. [CrossRef] 4. Noffsinger AE, Miller MA, Cusi MV, Fenoglio-Preiser CM. The pattern of cell proliferation in neoplastic and non-neoplastic lesions of ulcerative colitis. Cancer. 1996
  5. 78(11):2307-2312. [CrossRef] 5. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol. 1991
  6. 138(4):867-873. 6. Biasco G, Paganelli GM, Miglioli M, Barbara L. Cell proliferation biomarkers in the gastrointestinal tract. J Cell Biochem Suppl. 1992
  7. 16G:73-78. [CrossRef] 7. Andersen SN, Rognum TO, Bakka A, Clausen OP. Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis. Mol Pathol. 1998
  8. 51(6):327-332. [CrossRef] 8. Shinozaki M, Watanabe T, Kubota Y, et al. High proliferative activity is associated with dysplasia in ulcerative colitis. Dis Colon Rectum. 2000
  9. 43(10)(suppl):S34-S39. [CrossRef] 9. ASGE Technology Committee, Song LM, Adler DG, et al. Narrow band imaging and multiband imaging. Gastrointest Endosc. 2008
  10. 67(4):581-589. [CrossRef] 10. Bisschops R, Bessissow T, Joseph JA, et al. Chromoendoscopy versus narrow band imaging in UC: a prospective randomized controlled trial. Gut. 2018
  11. 67(6):1087-1094. [CrossRef] 11. Esaki M, Kubokura N, Kudo T, Matsumoto T. Endoscopic findings under narrow band imaging colonoscopy in ulcerative colitis. Dig Endosc. 2011
  12. 23(suppl 1):140-142. [CrossRef] 12. Guo T, Qian JM, Yang AM, Li Y, Zhou WX. Narrow-band imaging colonoscopy to assess mucosal angiogenesis in ulcerative colitis. Gastroenterol Res Pract. 2019
  13. 8312624. [CrossRef] 13. Lewis JD, Chuai S, Nessel L, et al. Use of the non-invasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008
  14. 14(12):1660-1666. [CrossRef] 14. Frăţilă OC, Iliaş TI. COX-2 and Ki-67 immunohistochemic